Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
Authors:
- Piotr KolczewskiPKPiotr Kolczewski
- Mirosław ParafiniukMPMirosław Parafiniuk
- Piotr ZawodnyPZPiotr Zawodny
- Rashad HaddadRHRashad Haddad
- Agnieszka NalewczyńskaANAgnieszka Nalewczyńska
- Agnieszka Kinga KolasaAKAgnieszka Kinga Kolasa
- Barbara WiszniewskaBWBarbara Wiszniewska
- Sophie MenkesSMSophie Menkes
- Alexander BaderABAlexander Bader
- Giorgio StabileGSGiorgio Stabile
- Nicola ZerbinatiNicola Zerbinati
Open Access
- 16 December 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (12) , 1571
Abstract
Vaginal laxity (VL) and genitourinary syndrome of menopause (GSM), as well as aesthetic changes in the vulvar skin, often occur together and cause physical, psychological, and functional problems for women and their partners. The current study evaluated the efficacy of a nonsurgical radiofrequency device (RF) procedure combined with hyaluronic acid (HA) injection into the skin of the labia majora on clinical, histological, and aesthetic levels. Twenty women with GSM and VL, aged between 36 and 72 (mean age 53.4), were treated with bipolar RF SECTUM, vaginal and vulvar application, as well as with a hyaluronic acid (HA) injection into the skin of the labia majora. The Vaginal Laxity Questionnaire (VLQ), Vaginal Health Index (VHI), and Female Sexual Function Index (FSFI) were used to examine the clinical effects of the operations. The Global Aesthetic Improvement Scale was utilized to measure patient satisfaction. On a histochemical level, the concentrations of elastin and collagen in the vaginal wall and vulvar skin were examined. Results: There was significantly higher patient satisfaction and a considerable clinical improvement across all areas of analysis. On the histochemical level, elastin and collagen fiber concentration increased after the treatment protocol both in the vulvar skin and in the vaginal wall: elastin in the vaginal wall, 11.4%, and in the vulvar skin, 61%; collagen in the vaginal wall, 26%, and in the vulvar skin, 27%. The current study demonstrated the efficacy and safety of this nonsurgical RF procedure combined with a hyaluronic acid (HA) injection into the skin of the labia majora on clinical, histochemical, and aesthetic levels.Keywords
This publication has 50 references indexed in Scilit:
- Radiofrequency facial rejuvenation: Evidence-based effectJournal of the American Academy of Dermatology, 2011
- Behavior and Symptom Change Among Women Treated with Placebo for Sexual DysfunctionThe Journal of Sexual Medicine, 2011
- Radiofrequency Treatment of Vaginal Laxity after Vaginal Delivery: Nonsurgical Vaginal TighteningThe Journal of Sexual Medicine, 2010
- Efficacy and tolerability of local estrogen therapy for urogenital atrophyMenopause, 2010
- ACOG Committee Opinion No. 378: Vaginal “Rejuvenation” and Cosmetic Vaginal ProceduresObstetrics & Gynecology, 2007
- A Randomized Trial to Determine the Influence of Laser Therapy, Monopolar Radiofrequency Treatment, and Intense Pulsed Light Therapy Administered Immediately after Hyaluronic Acid Gel ImplantationDermatologic Surgery, 2007
- Hyaluronic acid fillersDermatologic Therapy, 2006
- Safety of radiofrequency treatment over human skin previously injected with medium-term injectable soft-tissue augmentation materials: A controlled pilot trialLasers in Surgery and Medicine, 2006
- Effects of monopolar radiofrequency treatment over soft‐tissue fillers in an animal model: Part 1Lasers in Surgery and Medicine, 2005
- The pitfalls of vaginal constructionBJU International, 2005